The push for innovation drives both scientific discovery and transformative business strategies. Whether you’re an industry leader or a new market entrant, you want creative thinking and a clear path to future growth – and that’s exactly what our dedicated lawyers deliver.
Innovators and investors across the life sciences sector rely on our multidisciplinary team for help in tackling highly complex transactions and legal issues. From biotech firms to medical device manufacturers, and from private equity investors to pharmaceutical giants, we work with all industry players to help navigate the daunting business challenges that arise where innovation and regulation intersect.
At any stage in the life cycle, from the creation of a promising new therapy through commercialization, product licensing and regulatory compliance, and whether negotiating strategic alliances or a complex global merger, we have the sector expertise and experience to develop strategies and solutions that work.
Searchlight Pharma Inc., 2020
Acted for Searchlight Pharma Inc. in its licensing and distribution agreement with Sprout Pharmaceuticals, Inc. for Addyir in connection with the treatment of Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women.
Bellus Health Inc., 2020
Acted for Bellus Health Inc. in its acquisition of the BLU-5937 and related P2X3 antagonists intellectual property assets from adMare BioInnovations' NEOMED Institute.